Mark Foletta
2017
In 2017, Mark Foletta earned a total compensation of $2.1M as Executive Vice President and Chief Financial Officer at Forte Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $145,088 |
|---|---|
| Option Awards | $1,696,383 |
| Salary | $304,808 |
| Other | $563 |
| Total | $2,146,842 |
Foletta received $1.7M in option awards, accounting for 79% of the total pay in 2017.
Foletta also received $145.1K in non-equity incentive plan, $304.8K in salary and $563 in other compensation.
Rankings
In 2017, Mark Foletta's compensation ranked 5,173rd out of 14,666 executives tracked by ExecPay. In other words, Foletta earned more than 64.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,173 out of 14,666 | 65th |
Division Manufacturing | 1,841 out of 5,772 | 68th |
Major group Chemicals And Allied Products | 548 out of 2,075 | 74th |
Industry group Drugs | 423 out of 1,731 | 76th |
Industry Pharmaceutical Preparations | 332 out of 1,333 | 75th |
Source: SEC filing on April 30, 2018.
Foletta's colleagues
We found three more compensation records of executives who worked with Mark Foletta at Forte Biosciences in 2017.